back-button

    Recombinant Human Erythropoietin Alfa

    Information about Recombinant Human Erythropoietin Alfa

    Recombinant human erythropoietin alfa uses

    Recombinant Human Erythropoietin Alfa is used in the treatment of anemia, anemia due to chemotherapy and anemia due to chronic kidney disease.

    How recombinant human erythropoietin alfa works

    Recombinant human erythropoietin alfa is an erythropoiesis-stimulating agent (ESA). It works by stimulating the bone marrow (soft tissue inside the bones which produces red blood cells) to produce more red blood cells.

    Common side effects of recombinant human erythropoietin alfa

    Rash, Injection site pain, Pulmonary thromboembolism, Arterial thromboembolism (blood clot in artery), Edema, Increased blood pressure, Hypersensitivity

    Available Medicine for Recombinant Human Erythropoietin Alfa

    • ₹990
      Septalyst Lifesciences Pvt.Ltd.
      1 variant(s)

    Content on this page was last updated on 06 October, 2017, by Dr. Varun Gupta (MD Pharmacology)